Quarterly Results- overall
Annual Results- Scale
Annual Results- Liquidity
Annual Results- Profitability/Return
Annual Results- Valuation
External Ecosystem
Sector
Major Subsidiaries/Associates
Key Clients
Products
Products
Product details
Operations
Capacity/ Production
Key Facilities
Key Certifications
Raw materials
Recent News
|
Cipla Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Read More
|
|
Cipla Appoints Former Castrol India CFO Rashmi Joshi as Independent Director for Five Years
Read More
|
|
Cipla appoints Rashmi Joshi as additional independent director
Read More
|
|
Cipla Ltd (BOM:500087) (Q2 2027) Earnings Call Highlights: Strong India Growth and US Ramp-Up ...
Read More
|
|
Cipla Q2 Results Review: ICICI Securities Remains Bullish After Inline Numbers; Check Target Price
Read More
|
|
Stock Picks Today: Maruti Suzuki, Bajaj Auto, L&T, Paytm, SBI Life, And More On Brokerages' Radar
Read More
|
|
Cipla Eyes Margin Rebound From FY28 As Middle East Freight Squeeze Hits Q2 Costs
Read More
|
|
Cipla Q2 results: Net profit plunges 35% to Rs 878 crore, revenue down 2.4% YoY; stock falls
Read More
|
|
Cipla Q2 Results: Profit falls 35%, Misses Estimates; Margin Contracts
Read More
|
|
Cipla Q2 Results: US sales meet expectations, margins narrow from last year
Read More
|
|
Cipla Q2FY27 slides: India revenue surges amid margin pressure By Investing.com
Read More
|
|
Cipla slips after Q2 PAT drops 35% YoY
Read More
|
|
CIPLA: Q2 growth and margin improved as management maintained ambitious U.S. launch-led guidance
Read More
|
|
CIPLA: Q2 revenue and profit fell YoY; NPPA litigation remains a significant exposure
Read More
|
|
CIPLA: Record One India revenue offset by lower consolidated EBITDA and PAT
Read More
|
|
Earnings call transcript: Cipla Q2 2027 revenue rises as stock slips 1.85%
Read More
|
|
Indian drugmaker Cipla misses profit view on US weakness, shares slip
Read More
|
|
Q2 results: L&T, Bajaj Auto, Maruti Suzuki, Cipla among 110 firms on Oct 27
Read More
|
|
Cipla Q2 Preview: Net Profit Seen Falling 29% As US Business Faces Headwinds
Read More
|
|
Gaurav Kaul Takes Charge as Managing Director & CEO of Cipla Health Ltd
Read More
|
|
Cipla reports record Q1FY27 revenue of ?7,119 crore
Read More
|
|
Cipla Ltd Estimates – NSE:CIPLA
Read More
|
|
Weekly Recap: Cipla Ltd below 200-week EMA and MF holdings up 2.6%
Read More
|
|
Gaurav Kaul appointed MD & CEO of Cipla Health
Read More
|
|
Maharashtra FDA cancels Cipla Pharma’s Pune drug sale licences after Bombay HC directed fresh hearing
Read More
|
|
FDA cancels Cipla’s wholesale drug licence at Pune warehouse | Hindustan Times
Read More
|
|
Reactin Plus Violations: Maharashtra FDA Cancels Cipla Warehouse Licences
Read More
|
|
Cipla on Maharashtra FDA action: ‘Disappointing’, says Pune warehouse follows protocols
Read More
|
|
Cipla's Pune Godown Loses Drug Licence Over 'Misbranding, Storage Violations'
Read More
|
|
FDA cancels wholesale drug sales license of Cipla Pharma & Life sciences Ltd
Read More
|
|
Maharashtra FDA Cancels Drug Sale Licence Of Pune Cipla Facility; Disappointing Decision, Says Firm
Read More
|
|
Tukaram Mundhe in action! Maharashtra FDA cancels Cipla's Pune drug sale licence
Read More
|